ALLO position history
The shares of Allogene Therapeutics (ALLO) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 605,100 shares, $1.4M, 0.34% of portfolio, New
- 2024 Q3: 1,050,118 shares, $2.9M, 0.69% of portfolio, Add +73.5%
- 2024 Q4: 1,240,118 shares, $2.6M, 0.67% of portfolio, Add +18.1%
- 2025 Q1: 1,380,118 shares, $2M, 0.57% of portfolio, Add +11.3%
- 2025 Q2: 1,380,118 shares, $1.6M, 0.43% of portfolio
- 2025 Q3: 1,380,118 shares, $1.7M, 0.42% of portfolio
- 2025 Q4: 1,380,118 shares, $1.9M, 0.44% of portfolio
- 2026 Q1: 1,370,118 shares, $3.3M, 0.76% of portfolio, Reduce −0.7%
- 2026 Q2: 2,000,000 shares, $4.2M, 0.79% of portfolio, Add +46.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|